NCT07639450
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07639450
Title N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors (Solid Tumors)
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hefei Xinzhu Biological Technology Co., Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS


No variant requirements are available.